Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (81-90 of 312) with videos related to

Pageof 32
Sort By:
The Journal of Urology|February 14, 2007
A temporary intraurethral prostatic stent relieves prostatic obstruction following transurethral microwave thermotherapyNeal D Shore, Martin K Dineen, Mark J Saslawsky, et al.
Urology Practice|June 20, 2024
Reply by AuthorsMohamad Abou Chakra, Neal D Shore, Erica S Brown, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 19, 2024
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologistsMohamad Moussa, Mohamad Abou Chakra, Neal D Shore, et al.
Cancer Treatment Reviews|April 13, 2024
First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United StatesRana R McKay, Alicia K Morgans, Neal D Shore, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2014
Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancerDesmond Padhi, Celestia S Higano, Neal D Shore, et al.
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
European Urology|November 1, 2011
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literatureGuru Sonpavde, Giuseppe Di Lorenzo, Celestia S Higano, et al.
European Urology Focus|July 30, 2017
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR TrialsNeal D Shore, Teuvo L Tammela, Christophe Massard, et al.
Reviews in Urology|May 5, 2018
The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients With Organ-confined Prostate Cancer: Rationale and DevelopmentDeepak A Kapoor, Neal D Shore, Gary M Kirsh, et al.
Prostate Cancer and Prostatic Diseases|September 7, 2023
Application of next-generation imaging in biochemically recurrent prostate cancerJudd W Moul, Neal D Shore, Kenneth J Pienta, et al.
Pageof 32

Showing results (81-90 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Urology|February 14, 2007
A temporary intraurethral prostatic stent relieves prostatic obstruction following transurethral microwave thermotherapyNeal D Shore, Martin K Dineen, Mark J Saslawsky, et al.
Urology Practice|June 20, 2024
Reply by AuthorsMohamad Abou Chakra, Neal D Shore, Erica S Brown, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|March 19, 2024
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologistsMohamad Moussa, Mohamad Abou Chakra, Neal D Shore, et al.
Cancer Treatment Reviews|April 13, 2024
First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United StatesRana R McKay, Alicia K Morgans, Neal D Shore, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2014
Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancerDesmond Padhi, Celestia S Higano, Neal D Shore, et al.
JAMA Oncology|May 9, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A ReviewMaha Hussain, Karim Fizazi, Neal D Shore, et al.
European Urology|November 1, 2011
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literatureGuru Sonpavde, Giuseppe Di Lorenzo, Celestia S Higano, et al.
European Urology Focus|July 30, 2017
Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR TrialsNeal D Shore, Teuvo L Tammela, Christophe Massard, et al.
Reviews in Urology|May 5, 2018
The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients With Organ-confined Prostate Cancer: Rationale and DevelopmentDeepak A Kapoor, Neal D Shore, Gary M Kirsh, et al.
Prostate Cancer and Prostatic Diseases|September 7, 2023
Application of next-generation imaging in biochemically recurrent prostate cancerJudd W Moul, Neal D Shore, Kenneth J Pienta, et al.
Pageof 32